Harold Atkins

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

David F. Stojdl, Brian D. Lichty, Benjamin R. tenOever et al. · Cancer Cell · 2003 · 848 citations · Full text

Life Sciences, Immunology, Oncology +14

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

David F. Stojdl, Brian D. Lichty, Shane Knowles et al. · Nature Medicine · 2000 · 816 citations

Life Sciences, Molecular Biology, Oncology +16

A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)

P. Som, Harold Atkins, D. Bandoypadhyay et al. · Journal of Computer Assisted Tomography · 1980 · 503 citations

Medicine, Nuclear Medicine, Radiology +15

Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [ ¹⁸ F]Fluorodeoxyglucose and [ ¹¹ C]Deoxyglucose

Martin Reivich, Abass Alavi, Alfred P. Wolf et al. · Journal of Cerebral Blood Flow & Metabolism · 1985 · 418 citations

Life Sciences, Biochemistry, Neuroscience +15

Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial

Harold Atkins, Marjorie A. Bowman, David Allan et al. · The Lancet · 2016 · 322 citations

Life Sciences, Hematology, Immunology +13